Ventas, Inc. $VTR Stock Holdings Lessened by Entropy Technologies LP

Entropy Technologies LP cut its holdings in Ventas, Inc. (NYSE:VTR) by 36.6% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 56,357 shares of the real estate investment trust’s stock after selling 32,569 shares during the period. Entropy Technologies LP’s holdings in Ventas were worth $4,609,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of the business. Healthcare of Ontario Pension Plan Trust Fund raised its stake in Ventas by 1,794.8% during the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 351,842 shares of the real estate investment trust’s stock worth $28,774,000 after acquiring an additional 333,273 shares during the period. Modern Wealth Management LLC boosted its stake in Ventas by 6.2% in the first quarter. Modern Wealth Management LLC now owns 3,204 shares of the real estate investment trust’s stock valued at $263,000 after acquiring an additional 188 shares during the period. Arrowstreet Capital Limited Partnership boosted its stake in Ventas by 142.8% in the first quarter. Arrowstreet Capital Limited Partnership now owns 396,563 shares of the real estate investment trust’s stock valued at $32,431,000 after acquiring an additional 233,254 shares during the period. Inceptionr LLC grew its holdings in shares of Ventas by 22.3% during the first quarter. Inceptionr LLC now owns 23,580 shares of the real estate investment trust’s stock valued at $1,928,000 after purchasing an additional 4,301 shares during the last quarter. Finally, Sei Investments Co. grew its holdings in shares of Ventas by 3.3% during the first quarter. Sei Investments Co. now owns 660,428 shares of the real estate investment trust’s stock valued at $54,010,000 after purchasing an additional 21,378 shares during the last quarter. Institutional investors own 94.18% of the company’s stock.

Analysts Set New Price Targets

VTR has been the topic of several recent research reports. The Goldman Sachs Group reissued a “buy” rating and issued a $110.00 price target on shares of Ventas in a report on Tuesday, May 19th. Barclays started coverage on Ventas in a research note on Tuesday, July 7th. They set an “equal weight” rating and a $99.00 price objective for the company. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $100.00 target price on shares of Ventas in a research report on Tuesday, June 16th. Jefferies Financial Group raised their target price on Ventas from $97.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, May 12th. Finally, Citigroup boosted their price target on shares of Ventas from $96.00 to $100.00 and gave the company a “buy” rating in a report on Friday, May 1st. Fifteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, Ventas has a consensus rating of “Moderate Buy” and an average price target of $96.50.

Ventas Price Performance

Shares of NYSE:VTR opened at $100.61 on Friday. The firm’s 50 day moving average is $88.17 and its two-hundred day moving average is $84.85. The firm has a market capitalization of $48.92 billion, a P/E ratio of 182.94, a PEG ratio of 2.16 and a beta of 0.70. The company has a current ratio of 0.25, a quick ratio of 0.25 and a debt-to-equity ratio of 0.95. Ventas, Inc. has a 52 week low of $65.15 and a 52 week high of $100.84.

Ventas (NYSE:VTR) last issued its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The business had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same quarter in the prior year, the firm posted $0.84 earnings per share. The business’s quarterly revenue was up 22.0% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Analysts anticipate that Ventas, Inc. will post 3.88 earnings per share for the current year.

Ventas Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th were paid a dividend of $0.52 per share. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $2.08 annualized dividend and a yield of 2.1%. Ventas’s payout ratio is presently 378.18%.

Insider Buying and Selling at Ventas

In other Ventas news, Director Michael J. Embler purchased 2,500 shares of the firm’s stock in a transaction dated Wednesday, June 3rd. The stock was bought at an average price of $78.81 per share, with a total value of $197,025.00. Following the completion of the purchase, the director owned 19,202 shares in the company, valued at $1,513,309.62. This trade represents a 14.97% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Walter C. Rakowich sold 1,152 shares of the firm’s stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $90.20, for a total value of $103,910.40. Following the transaction, the director directly owned 28,349 shares in the company, valued at $2,557,079.80. This trade represents a 3.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is owned by insiders.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.